Literature DB >> 32902664

Varied functions of immune checkpoints during cancer metastasis.

Ali Safarzadeh1,2, Mohsen Alizadeh1, Fatemeh Beyranvand2, Reza Falavand Jozaaee2, Khalil Hajiasgharzadeh1, Amir Baghbanzadeh1, Afshin Derakhshani1,3, Antonella Argentiero3, Behzad Baradaran4, Nicola Silvestris5,6.   

Abstract

Immune checkpoints comprise diverse receptors and ligands including costimulatory and inhibitory molecules, which play monumental roles in regulating the immune system. Immune checkpoints retain key potentials in maintaining the immune system homeostasis and hindering the malignancy development and autoimmunity. The expression of inhibitory immune checkpoints delineates an increase in a plethora of metastatic tumors and the inhibition of these immune checkpoints can be followed by promising results. On the other hand, the stimulation of costimulatory immune checkpoints can restrain the metastasis originating from diverse tumors. From the review above, key findings emerged regarding potential functions of inhibitory and costimulatory immune checkpoints targeting the metastatic cascade and point towards novel potential Achilles' heels of cancer that might be exploited therapeutically in the future.

Entities:  

Keywords:  Immune checkpoints; Immune system; Metastasis; Tumor

Mesh:

Substances:

Year:  2020        PMID: 32902664     DOI: 10.1007/s00262-020-02717-2

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  162 in total

Review 1.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

2.  Cancer: Inflaming metastasis.

Authors:  Alberto Mantovani
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

Review 3.  Overview on experimental models of interactions between nanoparticles and the immune system.

Authors:  Saeedeh Najafi-Hajivar; Parvin Zakeri-Milani; Hamed Mohammadi; Mehri Niazi; Mehdi Soleymani-Goloujeh; Behzad Baradaran; Hadi Valizadeh
Journal:  Biomed Pharmacother       Date:  2016-08-28       Impact factor: 6.529

Review 4.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

Review 5.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

Review 6.  Immune-Related Adverse Events Associated with Immune Checkpoint Blockade.

Authors:  Michael A Postow; Robert Sidlow; Matthew D Hellmann
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 7.  Inhibitory B7-family molecules in the tumour microenvironment.

Authors:  Weiping Zou; Lieping Chen
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

Review 8.  Global Cancer Incidence and Mortality Rates and Trends--An Update.

Authors:  Lindsey A Torre; Rebecca L Siegel; Elizabeth M Ward; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-14       Impact factor: 4.254

Review 9.  Targeting metastasis.

Authors:  Patricia S Steeg
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

Review 10.  Next generation of immune checkpoint therapy in cancer: new developments and challenges.

Authors:  Julian A Marin-Acevedo; Bhagirathbhai Dholaria; Aixa E Soyano; Keith L Knutson; Saranya Chumsri; Yanyan Lou
Journal:  J Hematol Oncol       Date:  2018-03-15       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.